| dc.creator |
TÜLÜCE, Kerim; RECEP TAYYIP ERDOGAN UNIVERSITY, FACULTY OF MEDICINE, MEDICINE PR. |
|
| dc.creator |
SEVİLGEN, Gökçen; FACULTY OF MEDICINE |
|
| dc.date |
2021-08-22T00:00:00Z |
|
| dc.date.accessioned |
2021-12-03T11:47:05Z |
|
| dc.date.available |
2021-12-03T11:47:05Z |
|
| dc.identifier |
https://dergipark.org.tr/tr/pub/sdutfd/issue/64600/837596 |
|
| dc.identifier |
10.17343/sdutfd.837596 |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/94275 |
|
| dc.description |
Pleural diseases appears as pleural effusion or pleuralthickening in the clinics. Pleural effusion is accumulationof fluid in the pleural space. In this study, weaimed to share the clinical features and postoperativepathological outcomes of patients who were hospitalizedfor pleural effusion or pleural thickening and underwentVideo Assisted Surgery (VATS).Materials and Methods58 patients who were referred to Recep Tayyip ErdoğanUniversity Thoracic Surgery Department dueto pleural effusion or pleural thickening between retrospectively. Age, sex, pleural biopsy pathologies,pleural fluid cytology and biochemical results and theduration of hospitalization were recorded. Pleural biopsypathologies were classified as malign and benignthen they were compared.ResultsOf the 58 patients who underwent VATS, 42 (72,4%)were male and 16 (27,6%) were female. The meanage was 58,4 ±16,2. Median age for men was 58,2and for women was 61,2. The mean duration of hospitalizationwas 4,1±1,4 day. 12 patients (20,6%)had pleural thickening accompanying pleural effusion.Pleural fluid cytology was benign in 44 patients(75,8%) and malignant in 14 patients (24,2%). Pleuralbiopsy pathology was reported as benign in 41patients (70,7%) and as malignant in 17 patients(29,3%). Pleural fluid cytology was benign in 29 patients(82.85%) and malignant in 6 patients (17.15%).In patients with malignant pleural biopsy 11 (64,7%)of them were adenocarcinoma. In patents with benignpleural biopsy 29 (70,7%) of them were chronic activeinflamation.ConclusionAs a result of our analysis we suggest that VATS is aminimal invasive method that can be used effectiveand safely in both diagnosis and treatment of pleuraldisease. |
|
| dc.description |
Plevral hastalıklar klinikte karşımıza plevral kalınlaşmave plevral efüzyon olarak çıkmaktadır. Plevralefüzyon, plevral boşlukta sıvı birikmesidir. Çalışmamızda,plevral efüzyon veya plevral kalınlaşma nedeniile kliniğimize yatırdığımız ve Video Yardımlı TorakoskopikCerrahi (VATS) yaptığımız hastaların kliniközelliklerini ve postoperatif patolojik sonuçlarını literatürbilgileri eşliğinde paylaşmayı amaçladık.Gereç ve Yöntem2017 Ocak ile 2020 Ekim arasında plevral efüzyonve plevral kalınlaşma nedeniyle Recep Tayyip ErdoğanÜniversitesi Eğitim Araştırma Hastanesi GöğüsCerrahisi Kliniği’ne yatırılan ve VATS uygulanan 58hastanın dosyaları retrospektif olarak incelendi. Hastalarınyaş, cinsiyet, hastanede yatış süreleri belirlendi.Plevral sıvıların biyokimyasal testleri, sitolojileri,plevral biyopsi sonuçları ve hastanede yatış sürelerikaydedildi. Plevral biyopsilerin patolojileri malign vebenign olarak ayrılıp karşılaştırmalı olarak incelendi.BulgularVATS ile biyopsi yapılan 58 hastanın 42’si (%72,4)erkek, 16’sı (%27,6) kadındı. Ortalama yaş 58,4±16,2 idi. Erkeklerin yaş ortalaması 58,2, kadınlarınyaş ortalaması ise 61,2 idi. Hastanede yatış süresiortalama 4,1±1,4 gün idi. Hastaların 12’sinde (%20,6) plevral efüzyona eşlik eden plevral kalınlaşmamevcuttu. Plevral sıvı sitolojilerine bakıldığında 44(%75,8) hastanın benign, 14 (%24,2) hastanın malignsitoloji olduğu görüldü. Biyopsi sonucu 17 (%29,3)hastada malign iken 41 (%70,7) hasta benign olarakdeğerlendirildi. Malign olarak sonuçlanan hastaların11’i (%64,7) adenokarsinom idi. Benign sonuçların ise29’u (%70,7) kronik aktif inflamasyon olarak sonuçlandı.SonuçAnalizlerimizin sonucunda, VATS’ın plevral hastalıklarıntanı ve tedavisinde güvenle kullanılabilecek efektifminimal invaziv bir yöntem olduğunu düşünüyoruz. |
|
| dc.format |
application/pdf |
|
| dc.language |
tr |
|
| dc.publisher |
Süleyman Demirel Üniversitesi |
|
| dc.publisher |
Süleyman Demirel University |
|
| dc.relation |
https://dergipark.org.tr/tr/download/article-file/1437450 |
|
| dc.source |
Volume: 28, Issue: 2
269-274 |
en-US |
| dc.source |
1300-7416 |
|
| dc.source |
2602-2109 |
|
| dc.source |
SDÜ Tıp Fakültesi Dergisi |
|
| dc.subject |
Pleural effusion,VATS,Biopsy |
|
| dc.subject |
Plevral efüzyon,VATS,Biyopsi |
|
| dc.title |
EFFECTIVENESS OF VATS IN PLEURAL DISEASES |
en-US |
| dc.title |
PLEVRAL HASTALIKLARIN TANISINDA VATS’IN ETKİNLİĞİ |
tr-TR |
| dc.type |
info:eu-repo/semantics/article |
|
| dc.citation |
1. Hallifax RJ, Corcoran JP, Ahmed A, Nagendran M, Rostom H,
Hassan N, et al. Physician-based ultrasound-guided biopsy for
diagnosing pleural disease. Chest 2014;146:1001-6. |
|
| dc.citation |
2. Ali SJ, Light RW, Maldonado F. Pleuroscopy or video-assisted
thoracoscopic surgery for exudative pleural effusion: a comparative
overview. J Thorac Dis 2019;11(7):3207-3216. |
|
| dc.citation |
3. Atalay F, Ernam D, Atikcan Ş. Akciğer Kanseri ve Plevral Efüzyon.
Solunum Hastalıkları 2001; 12: 274-278. |
|
| dc.citation |
4. Loddenkemper R. Thoracoscopy: state of the art. Eur Respir J
1998; 11: 213-21. |
|
| dc.citation |
5. Collins TR, Sahn SA. Thoracocentesis. Clinical value, complications,
technical problems, and patient experience. Chest
1987;91:817-22. |
|
| dc.citation |
6. Thomas M, Ibrahim WH, Raza T, Mushtaq K, Arshad A, Ahmed
M, et al. Medical thoracoscopy for exudative pleural effusion:
an eight-year experience from a country with a young population.
BMC Pulm Med 2017;17:151. |
|
| dc.citation |
7. Porcel JM, Gasol A, Bielsa S, Civit C, Light SW, Salud A. Clinical
features and survival of lung cancer patients with pleural
effusions. Respirology 2015;20:654-9. |
|
| dc.citation |
8. Metintas M. Pleuroscopy. Turk Klin J Int Med Sci 2006; 2: 35-
41. |
|
| dc.citation |
9. Hatzinger M, Kwon ST, Langbein S, Kamp S, Hacker A, Alken
P. Hans Christian Jacobaeus: Inventor of human laparoscopy
and thoracoscopy. J Endourol 2006;20:848-50. |
|
| dc.citation |
10. Braimbridge MV. The history of thoracoscopic surgery. Ann
Thorac Surg 1993;56:610-4. |
|
| dc.citation |
11. Rahman NM, Ali NJ, Brown G, Chapman SJ, Davis RJO, Downer
RJ, et al. Local anaesthetic thoracoscopy: British Thoracic
Society Pleural Disease Guideline 2010. Thorax 2010;65 Suppl
2:ii54-60. |
|
| dc.citation |
12. Ernst A, Hersh CP, Herth F, Thurer R, LoCicero 3rd J, Beamis J,
et al. A novel instrument for the evaluation of the pleural space:
an experience in 34 patients. Chest 2002;122:1530-4. |
|
| dc.citation |
13. Diaz-Guzman E, Dweik RA. Diagnosis and management of
pleural effusions: a practical approach. Compr Ther Winter
2007; 33: 237-46. |
|
| dc.citation |
14. Light RW. Pleural effusion. N Engl J Med 2002;346: 1971-7. |
|
| dc.citation |
15. Ünlü M, Şahin Ü, Akkaya A, Doğan A. Plevral efüzyonların etyolojisinin
araştırılması. Solunum Hastalıkları 2001; 12: 212-5. |
|
| dc.citation |
16. Şenyiğit A, Işık FB, Coşkunsel N, Anık H, Özbay B, Topçu F.
305 plevral efüzyonlu vakanın incelenmesi. Solunum Hastalıkları
1996; 7: 395-404. |
|
| dc.citation |
17. Kart L, Gülmez İ, Kiraz K, Demir R, Özesmi M. Plörezilerde
etyolojik faktörler. Solunum Hastalıkları 1998; 9: 619-26. |
|
| dc.citation |
18. Conner BD, Lee CG, Branca P, Rogers JT, Rodriguez RM, Light
RW. Variations in pleural fluid WBC count and differential
couts with different sample containers and different methods.
Chest 2003; 123:1181-7. |
|
| dc.citation |
19. Light RW. Pleural diseases. 4th ed. California: A WaWerly Co,
2001;1-196. |
|
| dc.citation |
20. Heffner JE, Brown LK, Barbieri CA. Diagnostic value of test
that discriminate between exudative and transudative pleural
effusions. Chest 1997;111:970-80. |
|
| dc.citation |
21. Kinasewitz, GT. Transudative pleural effusions. Eur Respir J
1997; 10: 714-718. |
|
| dc.citation |
22. Sahn SA. State of the art. The pleura. Am Rev Respir Dis 1988;
138: 184- 234. |
|
| dc.citation |
23. Yim AP, Chung SS, Lee TW, Lam CK, Ho JK. Thoracoscopic
management of malignant pleural effusions. Chest 1996;
109:1234-8. |
|
| dc.citation |
24. Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma:
A prospective study of 188 consecutive patients. Cancer
1993; 72: 389-93. |
|
| dc.citation |
25. Wu H, Khosla R, Rohatgi PK, Chauhan SS, Paal E, Chen W.
The minimum voluma of pleural fluid to diagnose malignant
pleural effusion. A retrospective study. Lung India 2017;34:34 |
|
| dc.citation |
26. Bayrak MG, Erkan L, Uzun O, Fındık S, Atıcı AG, Özkaya Ş.
Plevral Efüzyonlu 153 Hastanın Değerlendirilmesi. Solunum
Hastalıkları 2006; 17: 66-72. |
|
| dc.citation |
27. Köktürk O, Sezer Ö, Ekim NN, Türktaş H. Plevral Efüzyonlu
112 Olgunun Değerlendirilmesi. Gazi Tıp Dergisi 1990; 2: 90-5. |
|
| dc.citation |
28. Öz N, Sarper A, Dertsiz L, Erdoğan A, Ertuğ Z, Demircan A, Işın
E. Plevral Effüzyonlu Olgularda Tanı ve Tedavi Amaçlı Video
Yardımlı Torasik Cerrahi. GKDC Dergisi 1998; 6: 351-356. |
|
| dc.citation |
29. Hucker J, Bhatnagar NK, al-Jilaihawi AN, Forrester-Wood CP.
Thoracoscopy in the diagnosis and management of recurrent
pleural effusions. Ann Thorac Surg 1991; 52: 1145-7. |
|
| dc.citation |
30. Kodak A, Öğüş AC, Özdemir T. Plevral sıvılarda transuda-eksuda
ayırımında kolesterol değerleri ile serum-plevral sıvı albumin
gradientinin Light kriterleri ile karşılaştırılması. Solunum
1999;3:100-2. |
|
| dc.citation |
31. Tokgöz F, Göksenoglu N, Bodur Y, Aksoy E, Aktaş O, Sevim
T. Retrospective Analysis of 240 Cases with Pleural Effusion.
Eurasian J Pulmonol 2014; 16: 78-83. |
|
| dc.citation |
32. Hamm H, Brohan U, Bohmer R, Missmahl HP. Cholesterol in
pleural effusions-a diagnostic aid. Chest 1987;92:296-302. |
|
| dc.citation |
33. Marel M, Stastny B, Melínová L, Svandová E, Light RW. Diagnosis
of pleural effusions. Experience with clinical studies,
1986 to 1990. Chest 1995;107:1598-603. |
|
| dc.citation |
34. Romero-Candeira S, Hernández L, Romero-Brufao S, Orts D,
Fernández C, Martín C. Is it meaningful to use biochemical parameters
to discriminate between transudative and exudative
pleural effusions? Chest 2002;122:1524-9. |
|
| dc.citation |
35. Menzies R, Charbonneau M. Thoracoscopy for the diagnosis of
pleural disease. Ann Intern Med 1991; 114: 271–276. |
|
| dc.citation |
36. Chakrabarti B, Ryland I, Sheard J, Warburton CJ, Earis JE. The
role of Abrams percutaneous pleural biopsy in the investigation
of exudative pleural effusions. Chest 2006; 129: 1549–1555. |
|
| dc.citation |
37. Sheth S, Hamper UM, Stanley DB, Wheeler JH, Smith PA. US
guidance for thoracic biopsy: a valuable alternative to CT. Radiology
1999; 210: 721– 726. |
|
| dc.citation |
38. Kürkçüoğlu C, Karaoğlanoğlu N, Eroğlu A, Ünlü M. Pleural effusions
and video assisted thoracoscopy. J. Turk. Thorac. Cardiovasc.
Surg. 8, 712-714. |
|
| dc.citation |
39. Valchev D., Peeva K., Petrov D. Are postoperative pain and patient
satisfaction influenced by the number of ports in VATS for
malignant pleural effusion treatment? Postgraduate Med 2020,
Vol. 132, No. 1, 62–65. |
|
| dc.citation |
40. Dumanlı A., Öz G. Vats pleura biopsy experiences: Analysis
of 35 cases. Med J SDU / SDÜ Tıp Fak Derg. 2020:27(3):261-
266. |
|